Novabay Pharmaceuticals shares are trading higher after the company received the right to commercialize amniotic tissue allograft from Biostem Technologies, which is intended for use as a protective covering during the repair of ocular surfaces.
Benzinga Newsdesk - Sep 11, 2023, 8:24AM